Clinical trial
Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease…
NCT00449436 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00449436 |
|---|---|
| Title | Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults |
| Official title | A Randomised, Open-Label Study to Evaluate the Efficacy and Safety of a Treatment Optimisation With Trizivir During 96 Weeks After a First Antiretroviral Treatment in HIV-1 Infected Subjects. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | TRIZIVIR, Non-nucleoside reverse transcriptase inhibitor, Boosted Protease Inhibitor |
| Enrollment | 152 |
| Start date | Jan 10, 2005 |
| Primary completion | Dec 12, 2007 |
| Completion | Dec 13, 2007 |
| First posted | Mar 20, 2007 |
| Last update posted | Oct 15, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: